MediPrint Lens (Allergy/Comfort)
Ocular Allergy / Contact Lens Comfort
Pre-clinical/ResearchActive
Key Facts
Indication
Ocular Allergy / Contact Lens Comfort
Phase
Pre-clinical/Research
Status
Active
Company
About MediPrint Ophthalmics
MediPrint Ophthalmics is a private, clinical-stage biotech company addressing significant unmet needs in ophthalmology through its proprietary MediPrint™ contact lens drug delivery platform. The company has completed a Phase 2a study and is advancing its lead glaucoma program into Phase 2b, with a pipeline targeting multi-billion dollar markets. With a clear path to Phase 3 data and a focus on non-invasive, patient-friendly therapies, MediPrint aims to establish a new standard of care in ocular drug delivery.
View full company profile